Carnot Laboratories
Clinical trials sponsored by Carnot Laboratories, explained in plain language.
-
Could a shot every two weeks beat weekly diabetes drugs?
Disease control Not yet recruitingThis study tests a new medicine called bofanglutide (GZR18) for adults with type 2 diabetes whose blood sugar is not well controlled with metformin alone. Bofanglutide is given as a shot under the skin every two weeks, and researchers compare it to semaglutide, a weekly injection…
Phase: PHASE3 • Sponsor: Carnot Laboratories • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New Weight-Loss drug bofanglutide takes on semaglutide in major trial
Disease control Not yet recruitingThis study tests a new drug called bofanglutide (GZR18) against the existing drug semaglutide for weight loss in 352 Latin American adults with overweight or obesity. Participants receive injections every two weeks (bofanglutide) or weekly (semaglutide) for 36 weeks, along with d…
Phase: PHASE3 • Sponsor: Carnot Laboratories • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC